Moderate or Severe Opioid Use Disorder

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Braeburn Pharmaceuticals
Braeburn PharmaceuticalsPA - Plymouth Meeting
1 program
1
CAM2038Phase 21 trial
Active Trials
NCT02611752Completed47Est. Apr 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Braeburn PharmaceuticalsCAM2038

Clinical Trials (1)

Total enrollment: 47 patients across 1 trials

A Multiple Dose Opioid Challenge Study

Start: Oct 2015Est. completion: Apr 201647 patients
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space